Categories: News

Completion of Name Change and Consolidation

VANCOUVER, BC / ACCESSWIRE / March 28, 2019 / Canland Health Corp. (formerly, 1155176 B.C. LTD.) (the “Company“) is pleased to announce that effective March 27, 2019 it has completed its name change from “1155176 B.C. LTD.” to “Canland Health Corp.” and the consolidation of its issued and outstanding class A common shares on the basis of 50 pre-consolidation shares for each 1 post-consolidation share for shareholders of record as of the end of business day on March 27, 2019. No fractional shares have been issued as a result of the consolidation and fractional shares have been rounded down to the nearest whole number of shares. The Company’s new CUSIP number is “137640108”.

For further information please contact:

Ron Miles, CEO & Director
E-mail: rmiles1@telus.net

Statements contained in this press release are made as of the date of this press release. The Company disclaims any intent or obligation to update publicly any forward-looking information or other information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

SOURCE: Canland Health Corp.

View source version on accesswire.com:
https://www.accesswire.com/540591/Completion-of-Name-Change-and-Consolidation

user

Recent Posts

LivaNova to Announce First-Quarter 2024 Results

LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call…

3 hours ago

Viz.ai Names Michael Herring as Chief Financial Officer

Seasoned financial leader brings experience at leading companies in healthcare and software as a service…

3 hours ago

Babson Diagnostics to Launch Transformative Blood Testing Service with Leading Retail Partners

Babson introduces BetterWay™ blood testing, which uses a pea-sized amount of blood collected from a…

3 hours ago

BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables

Experienced Life Sciences Executive to Support Cosmeceuticals and Injectables Growth for New CDMO Business UnitVancouver,…

3 hours ago

Narconon Suncoast Champions Awareness During National Drug and Alcohol Facts Week

CLEARWATER, FL / ACCESSWIRE / March 21, 2024 / Narconon Suncoast is proud to join…

3 hours ago